NCT07051512View on ClinicalTrials.gov

Effect of Different Doses Of Intrathecal Dexmedetomidine In Combination With Bupivacaine On Spinal Anesthesia

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Spinal Anesthesia EvaluationAnalgesicIntrathecal Anesthesia
Interventions
DRUG

dexmedetomidine 4μg

patients received (0.5% hyperbaric bupivacaine 12.5 mg + dexmedetomidine 4μg)

DRUG

dexmedetomidine 8 μg

patients received (0.5% hyperbaric bupivacaine 12.5 mg + dexmedetomidine 8 μg)

DRUG

dexmedetomidine 10 μg

patients received (0.5% hyperbaric bupivacaine 12.5 mg + dexmedetomidine 10 μg).

Trial Locations (1)

Unknown

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER